Distinct functional domains of TGF-β bind receptors on endothelial cells

Growth Factors

Volumn 17, Issue 1, 1999, Pages 63-73

  Qian, Su Wen ^a   Dumont, Nancy ^b   O'Connor Mccourt, Maureen D ^b   Burmester, James K ^c  

^a Edge BioSystems   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c MARSHFIELD CLINIC   (United States)

Author keywords

Crosslinking; GPI linked protein; Growth factor; Mutational analysis; Protein structure

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMINO ACID; BINDING PROTEIN; CELL SURFACE PROTEIN; CHIMERIC PROTEIN; ENDOGLIN; GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; CROSS LINKING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; VASCULAR ENDOTHELIUM;

EID: 0032882115     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977199909001063     Document Type: Article

References (56)

1. Archer, S.J., Bax, A., Roberts, A.B., Sporn, M.B., Ogawa, Y., Piez, K.A., Weatherbee, J.A., Tsang, M.L., Lucas, R., Zheng, B.L., Wenker, J. and Torchia, D.A. (1993) Transforming growth factor β1: NMR signal assignments of the recombinant protein expressed and isotopically enriched using Chinese hamster ovary cells. Biochemistry 32(4), 1152-1163.
2. Barbara, N.P., Wrana, J.L. and Letarte, M. (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J. Biol. Chem. 274(2), 584-594.
3. Beck, L.S., Chen, T.L., Hirabayashi, S.E., Deguzman, L., Lee, W.P., McFatridge, L.L., Xu, Y., Bates, R.L. and Ammann, A. J. (1990) Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-β1. Growth Factors 2(4), 273-282.
4. Brunner, A.M., Marquard, H., Malacko, A.R., Lioubin, M.N. and Purchio, A.F. (1989) Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor. Expression and characterization of mutant proteins. J. Biol. Chem. 264(23), 13 660-13 664.
5. Burmester, J.K., Qian, S.W., Roberts, A.B., Huang, A., Amatayakul-Chantler, S., Suardet, L., Odartchenko, N., Madri, J.A. and Sporn, M.B. (1993) Characterization of distinct functional domains of transforming growth factor-β. Proc. Natl. Acad. Sci. USA 90(18), 8628-8632.
6. Burmester, J.K., Qian, S.W., Ohlsen, D., Sporn, M.B. and Roberts, A.B. (1998) Mutational analysis of a transforming growth factor-β receptor binding site. Growth Factors 15, 231-242.
7. Castilla, A., Prieto, J. and Fausto, N. (1991) Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alfa therapy. N. Engl. J. Med. 324(14), 933-940.
8. Cheifetz, S., Weatherbee, J.A., Tsang, M.L.-S., Anderson, J.K., Mole, J.E., Lucas, R. and Massagué, J. (1987) The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell 48, 409-415.
9. Cheifetz, S. and Massagué, J. (1991) Isoform-specific transforming growth factor-β binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C. J. Biol. Chem. 266(31), 20767-20772.
10. Cheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabeus, C., Massagué, J. and Letarte, M. (1992) Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. Biol. Chem. 267(27), 19027-19030.
11. Crookston, K.P., Webb, D.J., Wolf, B.B. and Gonias, S.L. (1994) Classification of alpha 2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions. J. Biol. Chem. 269(2), 1533-1540.
12. Danielpour, D., Dart, L.L., Flanders, K.C., Roberts, A.B. and Sporn, M.B. (1989) Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol. 138(1), 79-86.
13. Daopin, S., Piez, K.A., Ogawa, Y. and Davies, D.R. (1992) Crystal structure of transforming growth factor-β2: An unusual fold for the superfamily. Science 257(5068), 369-373.
14. Dumont, N., O'Connor-McCourt, M.D. and Philip, A. (1995) Transforming growth factor-β receptors on human endometrial cells: Identification of the type I, II, and III receptors and glycosylphosphatidylinositol anchored TGF-β binding proteins. Mol. Cell. Endocrinol. 111, 57-66.
15. Feng, X.-H., Filvaroff, E.H. and Derynek, R. (1995) Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J. Biol. Chem. 270(41), 24237-24245.
16. Frolik, C.A., Wakefield, L.M., Smith, D.M. and Sporn, M.B. (1984) Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J. Biol. Chem. 259(17), 10 995-11 000.
17. Geiser, A.G., Burmester, J.K., Webbink, R., Roberts, A.B. and Sporn, M.B. (1992) Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. J. Biol. Chem. 267(4), 2588-2593.
18. Gougos, A. and Letarte, M. (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem. 265(15), 8361-8364.
19. Hahn, S.A., Hoque, A.T.M.S., Moskaluk, C.A., da Costa, L.T., Schutte, M., Rozenblum, E., Seymour, A.B., Weinstein, C.L., Yeo, C.J., Hruban, R.H. and Kern, S.E. (1996) Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56(3), 490-494.
20. Hanks, S.K., Armour, R., Baldwin, J.H., Maldonado, F., Spiess, J. and Holley, R.W. (1988) Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc. Natl. Acad. Sci. USA 85(1), 79-82.
21. Higuchi, R., Krummel, B. and Saiki, R.K. (1988) A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions. Nucleic Acids Res. 16(15), 7351-7367.
22. Hinck, A.P., Archer, S.J., Qian, S.W., Roberts, A.B., Sporn, M.B., Weatherbee, J.A., Tsang, M.L.-S., Lucas, R., Zheng, B.-L., Wenker, J. and Torchia, D.A. (1996) Transforming growth factor β1: Three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor β2. Biochemistry 35(26), 8517-8534.
23. Hoodless, P.A. and Wrana, J.L. (1998) Mechanism and function of signaling by the TGF-β superfamily. In: Current Topics in Microbiology and Immunology. Vol. 228, pp. 235-266.
24. Huang, S.S., Liu, Q., Johnson, F.E., Konish, Y. and Huang, J.S. (1997) Transforming growth factor β peptide antagonists and their conversion to partial agonists. J. Biol. Chem. 272(43), 27155-27159.
25. Isaka, Y., Brees, D.K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N.A. and Border, W.A. (1996) Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat. Med. 2(4), 418-423.
26. Khalil, N. and Greenberg, A.H. (1991) The role of TGF-β in pulmonary fibrosis. Ciba Found. Symp. 157, 194-207.
27. Kondaiah, P., Van Obberghen-Schilling, E., Ludwig, R.L., Dhar, R., Sporn, M.B. and Roberts, A.B. (1988) cDNA cloning of porcine transforming growth factor-β1 mRNAs. Evidence for alternate splicing and polyadenylation. J. Biol. Chem. 263(34), 18 313-18 317.
28. Kuruvilla, A.P., Shah, R., Hochwald, G.M., Liggitt, H.D., Palladino, M.A. and Thorbecke, G.J. (1991) Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 88(7), 2918-2921.
29. Lee, S.J. and Nathans, D. (1988) Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. J. Biol. Chem. 263(7), 3521-3527.
30. Lopez-Casillas, F., Wrana, J.L. and Massagué, J. (1993) Betaglycans presents ligand to the TGF-β signaling receptor. Cell 73(7), 1435-1444.
31. MacGrogan, D., Pegram, M., Slamon, D. and Bookstein, R. (1997) Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15(9), 1111-1114.
32. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L.-Z., Lutterbaugh, J., Fan, R.S., Zborowska, F., Kinzler, K.W., Vogelstein, B., Brattain, M. and Willson, J.K.V. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268(5215), 1336-1338.
33. Massagué, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell. Biol. 6, 597-641.
34. Massagué, J. and Like, B. (1985) Cellular receptors for type β transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J. Biol. Chem. 260(5), 2636-2645.
35. Massagué, J. and Weis-Garcia, F. (1996) Serine/threonine kinase receptors: Mediators of transforming growth factor beta family signals. Cancer Surv. 27, 41-64.
36. McAllister, K.A., Grogg, K.M., Johnson, D.W., Gallione, C.J., Baldwin, M.A., Jackson, C.F., Helmbold, D.S., Markel, D.S., McKinnon, W.C., Murrell, J., McCormick, M.K., Pericak-Vance, M.A., Heutink, P., Oostra, B.A., Haitjema, T., Westerman, C.J.J., Porteous, M.E., Guttmacher, A.E., Letarte, M. and Marchuk, D.A. (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type I. Nat. Genet. 8(4), 345-351.
37. McAllister, K.A., Baldwin, M.A., Thukkani, A.K., Gallione, J.N., Berg, J.N., Porteous, M.E., Guttmacher, A.F. and Marchuk, D.A. (1995) Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type I suggest a dominant-negative effect of receptor function. Hum. Mol. Genet. 4(10), 1983-1984.
38. Mittl, P.R.E., Priestle, J.P., Cox, D.A., McMaster, G., Cerletti, N. and Grütter, M.C. (1996) The crystal structure of TGF-β3 and comparison to TGF-β2: Implications for receptor binding. Protein Sci. 5, 1261-1271.
39. Morello, J.P., Plamondon, J., Meyrick, B., Hoover, R. and O'Connor-McCourt, M.D. (1995) Transforming growth factor-β receptor expression on endothelial cells: Heterogeneity of type III receptor expression. J. Cell. Physiol. 165, 201-211.
40. Moses, H.L., Yang, E.Y. and Pietenpol, J.A. (1990) TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 63, 245-247.
41. O'Connor-McCourt, M.D. and Wakefield, L.M. (1987) Latent transforming growth factor beta in serum. A specific complex with alpha-2-macroglobulin. J. Biol. Chem. 262, 14090-14099.
42. Peltonen, J., Hsiao, L.L., Jaakkola, S., Sollberg, S., Aumailley, R., Timpl, R., Chu, M.L. and Uitto, J. (1991) Activation of collagen gene expression in keloids: Co-localization of type I and VI collagen and transforming growth factor-β1 mRNA. J. Invest. Dermatol. 97(12), 240-248.
43. Postlethwaite, A.E. and Seyer, J.M. (1995) Identification of a chemotactic epitope in human transforming growth factor-β1 spanning amino acid residues 358-374. J. Cell. Physiol. 164(13), 587-592.
44. Qian, S.W., Burmester, J.K., Merwin, J.R., Madri, J.A., Sporn, M.B. and Roberts, A.B. (1992) Identification of a structural domain that distinguishes the actions of the type 1 and 2 isoforms of transforming growth factor-β on endothelial cells. Proc. Natl. Acad. Sci. USA 89(14), 6290-6294.
45. Qian, S.W., Burmester, J.K., Sun, P.D., Huang, A., Ohlsen, D.J., Suardet, L., Flanders, K.C., Davies, D., Roberts, A.B. and Sporn, M.B. (1994) Characterization of mutated transforming growth factor-βs which possess unique biological properties. Biochemistry 33(40), 12 298-12 304.
46. Qian, S.W., Burmester, J.K., Tsang, M.L.S., Weatherbee, J.A., Hinck, A.P., Ohlsen, D.J., Sporn, M.B. and Roberts, A.B. (1996) Binding affinity of transforming growth factor-β to the type II receptor is determined by the C-terminal region of the molecule. J. Biol. Chem. 271(48), 30 656-30 662.
47. Roberts, A.B. and Sporn, M.B. (1990) The transforming growth factor-βs. In: Sporn, M.B. and Roberts, A.B. (Eds.): Peptide Growth Factors and Their Receptors. Handbook of Experimental Pharmacology. Vol. 1, Chapter 8, pp. 419-472. Springer: Berlin, Heidelberg.
48. Roberts, A.B. and Sporn, M.B. (1993) Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8, 1-9.
49. Schlunegger, M.P. and Grutter, M.C. (1992) An unusual feature revealed by the crystal structure at 2.2 Å resolution of human transforming growth factor-β2. Nature 358(6385), 430-434.
50. Sonis, S.T., Lindquist, L., Van Vugt, A., Stewart, A.A., Stain, K., Qu, G.-Y., Iwata, K.K. and Haley, J.D. (1994) Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor β3. Cancer Res. 54(5), 1135-1138.
51. Suardet, L., Gaide, A.-C., Calmes, J.-M., Sordat, B., Givel, J.-C., Eliason, J.F. and Odartchenko, N. (1992) Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors β1 and β2. Cancer Res. 52(13), 3705-3712.
52. Takagi, Y., Kohmura, H., Futamura, M., Kida, H., Tanemura, H., Shimokawa, K. and Saji, S. (1996) Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111(5), 1387-1389.
53. Tam, B.Y.Y. and Philip, A. (1998) Transforming growth factor-β receptor expression on human skin fibroblasts: Dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-β binding proteins. J. Cell. Physiol. 176, 553-564.
54. Thiagalingam, S., Lengauer, C., Leach, F.S., Schutte, M., Hahn, S.A., Overhauser, J., Willson, J.K., Markowitz, S., Hamilton, S.R., Kern, S.E., Kinzler, K.W. and Vogelstein, B. (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet. 13(3), 343-346.
55. 2-macroglobulin. J. Biol. Chem. 269(48), 30 402-30 406.
56. Yamashita, H., ten Dijke, P., Franzen, P., Miyazono, K. and Heldin, C.H. (1994) Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem. 269(31), 20 171-20 178.